New Once-Daily pill aims to tame ADHD symptoms in korean youth
Disease control
Not yet recruiting
This phase 3 trial tests whether viloxazine extended-release capsules, taken once daily, can safely reduce ADHD symptoms in Korean children and adolescents aged 6 to 17. Participants receive either the drug or a placebo for 8 weeks, with doses adjusted based on response. The stud…
Phase: PHASE3 • Sponsor: Alvogen Korea • Aim: Disease control
Last updated Jul 02, 2026 07:00 UTC